281 related articles for article (PubMed ID: 19035289)
1. Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product.
Elangovan S; Hsieh TC; Wu JM
Anticancer Res; 2008; 28(5A):2641-7. PubMed ID: 19035289
[TBL] [Abstract][Full Text] [Related]
2. gamma-Tocotrienol controls proliferation, modulates expression of cell cycle regulatory proteins and up-regulates quinone reductase NQO2 in MCF-7 breast cancer cells.
Hsieh TC; Elangovan S; Wu JM
Anticancer Res; 2010 Jul; 30(7):2869-74. PubMed ID: 20683025
[TBL] [Abstract][Full Text] [Related]
3. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
4. Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway.
Li T; Xiong Y; Wang Q; Chen F; Zeng Y; Yu X; Wang Y; Zhou F; Zhou Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4001-4011. PubMed ID: 31588803
[TBL] [Abstract][Full Text] [Related]
5. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
Wali VB; Bachawal SV; Sylvester PW
Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells.
Guo J; Sheng G; Warner BW
J Biol Chem; 2005 Oct; 280(43):35992-8. PubMed ID: 16126730
[TBL] [Abstract][Full Text] [Related]
8. Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells.
Shukla S; Gupta S
Cell Cycle; 2007 May; 6(9):1102-14. PubMed ID: 17457054
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative effects of gamma-tocotrienol on mammary tumour cells are associated with suppression of cell cycle progression.
Samant GV; Wali VB; Sylvester PW
Cell Prolif; 2010 Feb; 43(1):77-83. PubMed ID: 19922488
[TBL] [Abstract][Full Text] [Related]
10. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
Lin Z; Zhang X; Zhao F; Ru S
Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532
[TBL] [Abstract][Full Text] [Related]
11. Interaction between Polyamines and the Mitogen-Activated Protein Kinase Pathway in the Regulation of Cell Cycle Variables in Breast Cancer Cells.
Hu X; Washington S; Verderame MF; Manni A
Cancer Res; 2005 Dec; 65(23):11026-33. PubMed ID: 16322252
[TBL] [Abstract][Full Text] [Related]
12. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells.
Foster JS; Wimalasena J
Mol Endocrinol; 1996 May; 10(5):488-98. PubMed ID: 8732680
[TBL] [Abstract][Full Text] [Related]
13. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
[TBL] [Abstract][Full Text] [Related]
14. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
[TBL] [Abstract][Full Text] [Related]
15. Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells.
Wu Q; Qin SK; Teng FM; Chen CJ; Wang R
J Hematol Oncol; 2010 Oct; 3():43. PubMed ID: 21034513
[TBL] [Abstract][Full Text] [Related]
16. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.
Leng X; Connell-Crowley L; Goodrich D; Harper JW
Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
Srethapakdi M; Liu F; Tavorath R; Rosen N
Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
[TBL] [Abstract][Full Text] [Related]
18. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis.
Shen WH; Yin Y; Broussard SR; McCusker RH; Freund GG; Dantzer R; Kelley KW
J Biol Chem; 2004 Feb; 279(9):7438-46. PubMed ID: 14681231
[TBL] [Abstract][Full Text] [Related]
20. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
Pan W; Cox S; Hoess RH; Grafström RH
Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
